| scholarly article | Q13442814 |
| P2093 | author name string | V Turk | |
| D Turk | |||
| R Huber | |||
| D Musil | |||
| D Zucic | |||
| D. Musil | |||
| D. Turk | |||
| D. Zucic | |||
| I Mayr | |||
| I. Mayr | |||
| N Katunuma | |||
| N. Katunuma | |||
| R A Engh | |||
| R. Huber | |||
| R.A. Engh | |||
| T Popovic | |||
| T Towatari | |||
| T. Popovic | |||
| T. Towatari | |||
| V. Turk | |||
| P2860 | cites work | L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L | Q24531160 |
| ??? | Q28362284 | ||
| The refined 2.4 A X-ray crystal structure of recombinant human stefin B in complex with the cysteine proteinase papain: a novel type of proteinase inhibitor interaction | Q24556546 | ||
| Nucleotide and predicted amino acid sequences of cloned human and mouse preprocathepsin B cDNAs | Q24629322 | ||
| The 2.0 A X-ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases | Q27728538 | ||
| Structure of papain refined at 1.65 A resolution | Q27729147 | ||
| Binding of chloromethyl ketone substrate analogues to crystalline papain | Q27749019 | ||
| Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features | Q27860675 | ||
| On the size of the active site in proteases. I. Papain | Q27860826 | ||
| Cathepsin B, Cathepsin H, and cathepsin L | Q28277583 | ||
| Cathepsin B and cystatins: evidence for a role in cancer progression | Q28297146 | ||
| Thiol proteases. Comparative studies based on the high-resolution structures of papain and actinidin, and on amino acid sequence information for cathepsins B and H, and stem bromelain | Q28306293 | ||
| Gene structure of mouse cathepsin B. | Q34135867 | ||
| A protein engineering study of the role of aspartate 158 in the catalytic mechanism of papain | Q34366212 | ||
| Cysteinyl proteinases and their selective inactivation | Q34656277 | ||
| Isolation of a cDNA clone for the human lysosomal proteinase cathepsin B | Q35602619 | ||
| A new purification procedure of human kidney cathepsin H, its properties and kinetic data | Q36439062 | ||
| Homology of amino acid sequences of rat liver cathepsins B and H with that of papain | Q37614945 | ||
| Crystallization and Properties of Cathepsin B from Rat Liver | Q39292520 | ||
| Preparation of cathepsins B and H by covalent chromatography and characterization of their catalytic sites by reaction with a thiol-specific two-protonic-state reactivity probe. Kinetic study of cathepsins B and H extending into alkaline media and a | Q41822276 | ||
| Degradation of fructose-1,6-bisphosphate aldolase by cathepsin B. | Q42168981 | ||
| Inhibition of cysteine proteinases and dipeptidyl peptidase I by egg-white cystatin | Q42848203 | ||
| The specificity of cathepsin B. Hydrolysis of glucagon at the C-terminus by a peptidyldipeptidase mechanism | Q42933088 | ||
| Amino acid sequence of bovine spleen cathepsin B | Q44186952 | ||
| Preferential action of rat brain cathepsin B as a peptidyl dipeptidase converting pro-opioid oligopeptides | Q44349569 | ||
| Dissociation of ionizing groups in the binding cleft inversely controls the endo- and exopeptidase activities of cathepsin B. | Q44639948 | ||
| A comparison of the heme binding pocket in globins and cytochrome b5 | Q52868606 | ||
| An exploration of the primary specificity site of cathepsin B. | Q54346371 | ||
| Crystal and molecular structure of the sulfhydryl protease calotropin DI at 3·2 Å resolution | Q57973654 | ||
| Structure of actinidin, after refinement at 1.7 A resolution | Q67247280 | ||
| Chromophoric and fluorophoric peptide substrates cleaved through the dipeptidyl carboxypeptidase activity of cathepsin B | Q68209597 | ||
| Biosyntheses and processing of lysosomal cysteine proteinases in rat macrophages | Q68325544 | ||
| Crystallization of recombinant rat cathepsin B | Q68499647 | ||
| Porcine spleen cathepsin B is an exopeptidase | Q68884336 | ||
| Disulfide bridges of bovine spleen cathepsin B | Q68895366 | ||
| N-terminal variants of recombinant stefin B: effect on affinity for papain and cathepsin B | Q68920135 | ||
| Intracellular transport and processing of lysosomal cathepsin B | Q69439746 | ||
| Amino acid sequence of human liver cathepsin B | Q70059554 | ||
| The specificity of cathepsin B | Q71109630 | ||
| Extracellular presence of the lysosomal proteinase cathepsin B in rheumatoid synovium and its activity at neutral pH | Q71347962 | ||
| Cathepsins B and H from porcine spleen. Purification, polypeptide chain arrangements, and carbohydrate content | Q71431072 | ||
| Inhibitions by E-64 derivatives of rat liver cathepsin B and cathepsin L in vitro and in vivo | Q71479486 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | crystal structure | Q895901 |
| X-ray crystallography | Q826582 | ||
| P304 | page(s) | 2321-2330 | |
| 2321-30 | |||
| P577 | publication date | 1991-09-01 | |
| P1433 | published in | The EMBO Journal | Q1278554 |
| P1476 | title | The refined 2.15 A X-ray crystal structure of human liver cathepsin B: the structural basis for its specificity | |
| P478 | volume | 10 |
| Q71999767 | 37 Structure, properties, mechanisms, and assays ofcysteine protease inhibitors: Cystatins and E-64 derivatives |
| Q35683586 | 6. Cathepsin K inhibitors: their potential as anti-osteoporosis agents |
| Q33335117 | A cysteine protease is critical for Babesia spp. transmission in Haemaphysalis ticks |
| Q33370035 | A double-headed cathepsin B inhibitor devoid of warhead |
| Q36444217 | A major cathepsin B protease from the liver fluke Fasciola hepatica has atypical active site features and a potential role in the digestive tract of newly excysted juvenile parasites |
| Q47096973 | A novel type I cystatin of parasite origin with atypical legumain-binding domain. |
| Q46685164 | A primitive enzyme for a primitive cell: the protease required for excystation of Giardia |
| Q89769913 | A simple purification procedure of buffalo lung cathepsin H, its properties and influence of buffer constituents on the enzyme activity |
| Q31938614 | A tissue specific approach for analysis of membrane and secreted protein antigens from Haemonchus contortus gut and its application to diverse nematode species |
| Q41709011 | Addition of 2-(ethylamino)acetonitrile group to nitroxoline results in significantly improved anti-tumor activity in vitro and in vivo |
| Q27658897 | An Extracellular Disulfide Bond Forming Protein (DsbF) from Mycobacterium tuberculosis: Structural, Biochemical, and Gene Expression Analysis |
| Q85641063 | An insight into the anticancer activities of Ru(II)-based metallocompounds using docking methods |
| Q28538555 | An insight into the transcriptome of the digestive tract of the bloodsucking bug, Rhodnius prolixus |
| Q73669332 | Beta-cyclodextrin/epoxysuccinyl peptide conjugates: a new drug targeting system for tumor cells |
| Q58039002 | Binding modes of a new epoxysuccinyl–peptide inhibitor of cysteine proteases. Where and how do cysteine proteases express their selectivity? |
| Q93061468 | Biodegradable Polyphosphazene Based Peptide-Polymer Hybrids |
| Q42983501 | Biotin-labelled peptidyl diazomethane inhibitors derived from the substrate-like sequence of cystatin: targeting of the active site of cruzipain, the major cysteine proteinase of Trypanosoma cruzi |
| Q42566624 | Calculating pH-dependent free energy of proteins by using Monte Carlo protonation probabilities of ionizable residues |
| Q83993707 | Carboxypeptidase cathepsin X mediates beta2-integrin-dependent adhesion of differentiated U-937 cells |
| Q40426125 | Carboxypeptidases cathepsins X and B display distinct protein profile in human cells and tissues |
| Q28245818 | Cathepsin B |
| Q38966313 | Cathepsin B Inhibitors: Combining Dipeptide Nitriles with an Occluding Loop Recognition Element by Click Chemistry |
| Q42033638 | Cathepsin B carboxydipeptidase specificity analysis using internally quenched fluorescent peptides |
| Q26782938 | Cathepsin B is a New Drug Target for Traumatic Brain Injury Therapeutics: Evidence for E64d as a Promising Lead Drug Candidate |
| Q91849905 | Cathepsin B: A sellsword of cancer progression |
| Q41230243 | Cathepsin B: Basis Sequence: Mouse |
| Q42991927 | Cathepsin B: an alternative protease for the generation of an aggrecan 'metalloproteinase' cleavage neoepitope |
| Q38200056 | Cathepsin B: multiple roles in cancer |
| Q35941710 | Cathepsin K induces platelet dysfunction and affects cell signaling in breast cancer - molecularly distinct behavior of cathepsin K in breast cancer |
| Q24310097 | Cathepsin Z, a novel human cysteine proteinase with a short propeptide domain and a unique chromosomal location |
| Q37557828 | Chapter 4. Peptidases of trematodes |
| Q42680473 | Characterisation of Tc-cpl-1, a cathepsin L-like cysteine protease from Toxocara canis infective larvae |
| Q42160442 | Characterization by spectroscopic, kinetic and equilibrium methods of the interaction between recombinant human cystatin A (stefin A) and cysteine proteinases |
| Q28551898 | Characterization of a Recombinant Cathepsin B-Like Cysteine Peptidase from Diaphorina citri Kuwayama (Hemiptera: Liviidae): A Putative Target for Control of Citrus Huanglongbing |
| Q41709832 | Characterization of a secreted cystatin of the parasitic nematode Haemonchus contortus and its immune-modulatory effect on goat monocytes |
| Q41116581 | Chronic cathepsin inhibition by E-64 in Dahl salt-sensitive rats. |
| Q42132232 | Comparative behaviour of calpain and cathepsin B toward peptidyl acyloxymethyl ketones, sulphonium methyl ketones and other potential inhibitors of cysteine proteinases |
| Q71365991 | Conserved cystatin segments as models for designing specific substrates and inhibitors of cysteine proteinases |
| Q33673771 | Coordination of hepatocyte nuclear factor 4 and seven-up controls insect counter-defense cathepsin B expression |
| Q27617244 | Crystal structure of MHC class II-associated p41 Ii fragment bound to cathepsin L reveals the structural basis for differentiation between cathepsins L and S. |
| Q41845464 | Crystal structure of NS-134 in complex with bovine cathepsin B: a two-headed epoxysuccinyl inhibitor extends along the entire active-site cleft. |
| Q27622021 | Crystal structure of cathepsin X: a flip-flop of the ring of His23 allows carboxy-monopeptidase and carboxy-dipeptidase activity of the protease |
| Q27734780 | Crystal structure of human cathepsin K complexed with a potent inhibitor |
| Q42846520 | Crystal structure of human cathepsin S. |
| Q27734783 | Crystal structure of human osteoclast cathepsin K complex with E-64 |
| Q27748903 | Crystal structure of porcine cathepsin H determined at 2.1 A resolution: location of the mini-chain C-terminal carboxyl group defines cathepsin H aminopeptidase function |
| Q41437831 | Cwp84, a Clostridium difficile cysteine protease, exhibits conformational flexibility in the absence of its propeptide. |
| Q52541973 | Cystatin inhibition of cathepsin B requires dislocation of the proteinase occluding loop. Demonstration By release of loop anchoring through mutation of his110. |
| Q41852264 | Cysteine cathepsin activity regulation by glycosaminoglycans |
| Q38292676 | Cysteine cathepsins as regulators of the cytotoxicity of NK and T cells. |
| Q26860406 | Cysteine cathepsins: from structure, function and regulation to new frontiers |
| Q36600996 | Cysteine cathepsins: multifunctional enzymes in cancer |
| Q26771736 | Cysteine proteases as therapeutic targets: does selectivity matter? A systematic review of calpain and cathepsin inhibitors |
| Q91690107 | Cysteine-type cathepsins promote the effector phase of acute cutaneous delayed-type hypersensitivity reactions |
| Q38320195 | Defined characteristics of cathepsin B-like proteins from nematodes: inferred functional diversity and phylogenetic relationships |
| Q42812255 | Demonstration by electrospray mass spectrometry that the peptidyldipeptidase activity of cathepsin B is capable of rat cathepsin B C-terminal processing |
| Q41820346 | Differential changes in the association and dissociation rate constants for binding of cystatins to target proteinases occurring on N-terminal truncation of the inhibitors indicate that the interaction mechanism varies with different enzymes |
| Q42806191 | Dynamic imaging of protease activity with fluorescently quenched activity-based probes. |
| Q73837899 | E-64 analogues as inhibitors of cathepsin B. On the role of the absolute configuration of the epoxysuccinyl group |
| Q42084932 | E64 [trans-epoxysuccinyl-L-leucylamido-(4-guanidino)butane] analogues as inhibitors of cysteine proteinases: investigation of S2 subsite interactions |
| Q48061596 | Echinococcus multilocularis: Identification and functional characterization of cathepsin B-like peptidases from metacestode |
| Q34211633 | Eimeripain, a cathepsin B-like cysteine protease, expressed throughout sporulation of the apicomplexan parasite Eimeria tenella |
| Q41729834 | Endosomal proteolysis and MHC class II function |
| Q36518296 | Enzymatic and Structural Characterization of the Major Endopeptidase in the Venus Flytrap Digestion Fluid. |
| Q28473458 | Exoerythrocytic Plasmodium parasites secrete a cysteine protease inhibitor involved in sporozoite invasion and capable of blocking cell death of host hepatocytes |
| Q52274251 | Experimental measurement of the effective dielectric in the hydrophobic core of a protein. |
| Q41649990 | Expression and alteration of the S2 subsite of the Leishmania major cathepsin B-like cysteine protease |
| Q37059742 | Expression of virus-encoded proteinases: functional and structural similarities with cellular enzymes |
| Q45391769 | Expressional induction of Paralichthys olivaceus cathepsin B gene in response to virus, poly I:C and lipopolysaccharide |
| Q34317817 | Families of cysteine peptidases. |
| Q38454446 | Free-thiol Cys331 exposed during activation process is critical for native tetramer structure of cathepsin C (dipeptidyl peptidase I). |
| Q35155409 | Functional characterization of a cystatin from the tick Rhipicephalus haemaphysaloides |
| Q49552599 | Giardia Secretome Highlights Secreted Tenascins as a Key Component of Pathogenesis |
| Q35762858 | Giardia duodenalis Surface Cysteine Proteases Induce Cleavage of the Intestinal Epithelial Cytoskeletal Protein Villin via Myosin Light Chain Kinase |
| Q42735511 | Giardia duodenalis cathepsin B proteases degrade intestinal epithelial interleukin-8 and attenuate interleukin-8-induced neutrophil chemotaxis |
| Q38297464 | Hairpin loop mutations of chicken cystatin have different effects on the inhibition of cathepsin B, cathepsin L and papain |
| Q47260451 | High-molecular weight HPMA copolymer-adriamycin conjugates |
| Q33787274 | How does heparin prevent the pH inactivation of cathepsin B? Allosteric mechanism elucidated by docking and molecular dynamics |
| Q28205463 | Human Cathepsin H: Deletion of the Mini-Chain Switches Substrate Specificity from Aminopeptidase to Endopeptidase |
| Q22008028 | Human cathepsin F. Molecular cloning, functional expression, tissue localization, and enzymatic characterization |
| Q32021129 | Human cathepsin X: a novel cysteine protease of the papain family with a very short proregion and unique insertions |
| Q41861833 | Human tumour cathepsin B. Comparison with normal liver cathepsin B. |
| Q34092125 | Identification of lead compounds targeting the cathepsin B-like enzyme of Eimeria tenella |
| Q33935231 | Implication of cysteine proteases calpain, cathepsin and caspase in ischemic neuronal death of primates |
| Q24791513 | Importance of lysosomal cysteine proteases in lung disease |
| Q87673231 | Inhibition of cathepsin B activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin |
| Q44570302 | Inhibition of cathepsin B by Au(I) complexes: a kinetic and computational study |
| Q32061568 | Inhibition of cruzipain visualized in a fluorescence quenched solid-phase inhibitor library assay. D-amino acid inhibitors for cruzipain, cathepsin B and cathepsin L. |
| Q94505689 | Inhibition of mammalian cathepsins by Plesiomonas shigelloides |
| Q73992356 | Inhibition of papain with 2-benzyl-3,4-epoxybutanoic acid esters. Mechanistic and stereochemical probe for cysteine protease catalysis |
| Q90347617 | Isoforms of Cathepsin B1 in Neurotropic Schistosomula of Trichobilharzia regenti Differ in Substrate Preferences and a Highly Expressed Catalytically Inactive Paralog Binds Cystatin |
| Q36683887 | Isolation and expression pattern of a cDNA encoding a cathepsin B-like protease from Nicotiana rustica |
| Q26749121 | Lysosomal cathepsins and their regulation in aging and neurodegeneration |
| Q44068250 | Lysosomal cathepsins: structure, role in antigen processing and presentation, and cancer |
| Q24535678 | Lysosomal cysteine proteases: facts and opportunities |
| Q33857460 | Lysosomal cysteine proteases: more than scavengers |
| Q42156127 | MAIN software for density averaging, model building, structure refinement and validation. |
| Q41071640 | Maturation and degradation of beta-galactosidase in the post-Golgi compartment are regulated by cathepsin B and a non-cysteine protease |
| Q40220823 | Modulation of goat monocyte function by HCcyst-2, a secreted cystatin from Haemonchus contortus |
| Q36538973 | Molecular and biochemical characterization of a cathepsin B-like protease family unique to Trypanosoma congolense |
| Q41696667 | Molecular characterization of the cathepsin B of turbot (Scophthalmus maximus). |
| Q44387287 | Molecular cloning and characterization of cathepsin B from the hepatopancreas of northern shrimp Pandalus borealis |
| Q42020009 | Molecular cloning of a multidomain cysteine protease and protease inhibitor precursor gene from the tobacco hornworm (Manduca sexta) and functional expression of the cathepsin F-like cysteine protease domain |
| Q40232980 | Molecular dynamics studies of caspase-3. |
| Q28260087 | Nitroxoline impairs tumor progression in vitro and in vivo by regulating cathepsin B activity |
| Q27667908 | Novel mechanism of cathepsin B inhibition by antibiotic nitroxoline and related compounds |
| Q33638719 | Novel peptidyl aryl vinyl sulfones as highly potent and selective inhibitors of cathepsins L and B. |
| Q77376182 | Novel physiological functions of cathepsins B and L on antigen processing and osteoclastic bone resorption |
| Q74121583 | On the tissue/species dependence of cathepsin B isozymes |
| Q26866319 | Optimizing dentin bond durability: control of collagen degradation by matrix metalloproteinases and cysteine cathepsins |
| Q92974314 | Organoruthenated Nitroxoline Derivatives Impair Tumor Cell Invasion through Inhibition of Cathepsin B Activity |
| Q30368988 | Overview of protein structural and functional folds. |
| Q33893283 | Phylogenetic relationships and theoretical model of human cathepsin W (lymphopain), a cysteine proteinase from cytotoxic T lymphocytes. |
| Q37024703 | Possible involvement of radical intermediates in the inhibition of cysteine proteases by allenyl esters and amides |
| Q30848784 | Probing the specificity of cysteine proteinases at subsites remote from the active site: analysis of P4, P3, P2' and P3' variations in extended substrates. |
| Q41710645 | Proregion structure of members of the papain superfamily. Mode of inhibition of enzymatic activity |
| Q28612038 | Proteolysis and antigen presentation by MHC class II molecules |
| Q38268345 | Proteolysis mediated by cysteine cathepsins and legumain-recent advances and cell biological challenges |
| Q42159289 | Purification and characterization of a new cystatin inhibitor from Taiwan cobra (Naja naja atra) venom |
| Q43415674 | Purification and crystallization of human cathepsin D |
| Q33194078 | Purification of bovine cathepsin B: proteomic characterization of the different forms and production of specific antibodies |
| Q42662817 | Quail cystatin: isolation and characterisation of a new member of the cystatin family and its hypothetical interaction with cathepsin B. |
| Q90363169 | Regulation of the Proteolytic Activity of Cysteine Cathepsins by Oxidants |
| Q74643772 | Revisiting the S2 specificity of papain by structural analogs of Phe |
| Q24644675 | Role of the single cysteine residue, Cys 3, of human and bovine cystatin B (stefin B) in the inhibition of cysteine proteinases |
| Q42157735 | S2' substrate specificity and the role of His110 and His111 in the exopeptidase activity of human cathepsin B. |
| Q98389656 | SARS-CoV-2 Entry Inhibitors: Small Molecules and Peptides Targeting Virus or Host Cells |
| Q38928546 | SmCB2, a novel tegumental cathepsin B from adult Schistosoma mansoni |
| Q73958672 | Specificity of cathepsin B to fluorescent substrates containing benzyl side-chain-substituted amino acids at P1 subsite |
| Q27671668 | Structural Basis for Inhibition of Cathepsin B Drug Target from the Human Blood Fluke, Schistosoma mansoni |
| Q71843986 | Structural analysis of the catalytic site of AcCP-1, a cysteine proteinase secreted by the hookworm Ancylostoma caninum |
| Q27639074 | Structural basis for development of cathepsin B-specific noncovalent-type inhibitor: crystal structure of cathepsin B-E64c complex |
| Q24317192 | Structural basis for the biological specificity of cystatin C. Identification of leucine 9 in the N-terminal binding region as a selectivity-conferring residue in the inhibition of mammalian cysteine peptidases |
| Q42846000 | Structural determinants of specificity in the cysteine protease cruzain |
| Q26781444 | Structure and function of legumain in health and disease |
| Q73077056 | Structure based development of novel specific inhibitors for cathepsin L and cathepsin S in vitro and in vivo |
| Q27732608 | Structure of human beta-glucuronidase reveals candidate lysosomal targeting and active-site motifs |
| Q27636471 | Structure of human dipeptidyl peptidase I (cathepsin C): exclusion domain added to an endopeptidase framework creates the machine for activation of granular serine proteases |
| Q24561952 | Structure of human procathepsin L reveals the molecular basis of inhibition by the prosegment |
| Q27733264 | Structure of rat procathepsin B: model for inhibition of cysteine protease activity by the proregion |
| Q37714099 | Structure of the streptococcal endopeptidase IdeS, a cysteine proteinase with strict specificity for IgG. |
| Q34598268 | Structure-based development of specific inhibitors for individual cathepsins and their medical applications |
| Q71609088 | Studies on activation and inhibition of cathepsin B from buffalo liver |
| Q43601519 | Synthesis and hydrolysis by cathepsin B of fluorogenic substrates with the general structure benzoyl-X-ARG-MCA containing non-natural basic amino acids at position X. |
| Q98192661 | Synthesis of Novel Nitroxoline Analogs with Potent Cathepsin B Exopeptidase Inhibitory Activity |
| Q33194796 | Synthesis of a Diverse Library of Mechanism-Based Cysteine Protease Inhibitors |
| Q44855222 | Targeted drug delivery through the traceless release of tertiary and heteroaryl amines from antibody-drug conjugates |
| Q36326605 | Targeting Cathepsin B for Cancer Therapies |
| Q44809737 | The 2.0 A crystal structure and substrate specificity of the KDEL-tailed cysteine endopeptidase functioning in programmed cell death of Ricinus communis endosperm |
| Q55394029 | The Anticancer Activities of Some Nitrogen Donor Ligands Containing bis-Pyrazole, Bipyridine, and Phenanthroline Moiety Using Docking Methods. |
| Q36281760 | The N-terminal region of cystatin A (stefin A) binds to papain subsequent to the two hairpin loops of the inhibitor. Demonstration of two-step binding by rapid-kinetic studies of cystatin A labeled at the N-terminus with a fluorescent reporter group |
| Q53820838 | The active-site residue Cys-29 is responsible for the neutral-pH inactivation and the refolding barrier of human cathepsin B. |
| Q27642849 | The crystal structure of Pseudomonas avirulence protein AvrPphB: A papain-like fold with a distinct substrate-binding site |
| Q28237390 | The crystal structure of human cathepsin L complexed with E-64 |
| Q34809625 | The functional expression and characterisation of a cysteine peptidase from the invasive stage of the neuropathogenic schistosome Trichobilharzia regenti |
| Q73526016 | The high stability of cruzipain against pH-induced inactivation is not dependent on its C-terminal domain |
| Q36143863 | The role of cystatins in tick physiology and blood feeding. |
| Q42129985 | The secreted cathepsin L-like proteinases of the trematode, Fasciola hepatica, contain 3-hydroxyproline residues |
| Q27732574 | Three-dimensional structure of the human 'protective protein': structure of the precursor form suggests a complex activation mechanism |
| Q34668084 | Transcriptome analysis of host-associated differentiation in Bemisia tabaci (Hemiptera: Aleyrodidae). |
| Q85341798 | Triterpenoids as novel natural inhibitors of human cathepsin L |
| Q32060744 | Tumor protease-activated, pore-forming toxins from a combinatorial library. |
| Q28267848 | Two crystal structures for cathepsin D: the lysosomal targeting signal and active site |
| Q74219866 | Two-step mechanism of inhibition of cathepsin B by cystatin C due to displacement of the proteinase occluding loop |
| Q30366195 | VASP-E: specificity annotation with a volumetric analysis of electrostatic isopotentials. |
| Q74452039 | X-ray crystal structure of papain complexed with cathepsin B-specific covalent-type inhibitor: substrate specificity and inhibitory activity |
| Q61066436 | aziridinyl peptides as inhibitors of cysteine proteases: Effect of a free carboxylic acid function on inhibition |
| Q44206256 | gamma-Glutamyl thioester intermediate in glutaminase reaction catalyzed by Escherichia coli asparagine synthetase B. |
| Q44188806 | pH Dependence of inhibitors targeting the occluding loop of cathepsin B. |
Search more.